Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Caladrius Biosciences Inc (NASDAQ:CLBS)

4.29
Delayed Data
As of 1:15pm ET
 +0.01 / +0.23%
Today’s Change
2.65
Today|||52-Week Range
7.79
+51.59%
Year-to-Date
No recent news for Caladrius Biosciences Inc.

Today’s Trading

Previous close4.28
Today’s open4.30
Day’s range4.27 - 4.30
Volume3,361
Average volume (3 months)30,811
Market cap$38.1M
Dividend yield--
Data as of 1:15pm ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)+70.12%
Earnings growth (this year)+91.38%
Earnings growth (next 5 years)+42.90%
Revenue growth (last year)+56.90%
P/E ratioNM
Price/Sales0.53
Price/Book7.19

Competitors

 Today’s
change
Today’s
% change
APVOAptevo Therapeutics ...0.000.00%
KMPHKemPharm Inc+0.05+1.85%
HSGXHistogenics Corp+0.03+1.67%
ICCCImmuCell Corp-0.49-6.90%
Data as of 1:21pm ET, 08/16/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.94
Annual revenue (last year)$35.3M
Annual profit (last year)-$32.7M
Net profit margin-92.55%

Profile

Sector
Distribution Services
Industry
Wholesale Distributors
Chief Executive Officer &
Director
David J. Mazzo
Chief Financial Officer &
Senior Vice President
Joseph Talamo
Corporate headquarters
Basking Ridge, New Jersey

Forecasts